References
- Arias JL (2011). Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem, 11, 1-17. https://doi.org/10.2174/138955711793564024
- Baggstrom MQ, Stinchcombe TE, Fried DB, et al (2007). Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol, 2, 845-53. https://doi.org/10.1097/JTO.0b013e31814617a2
- Berg K, Zhai L, Chen M, Kharazmi A, Owen TC (1994). The use of a water-soluble formazan complex to quantitate the cell number and mitochondrial function of Leishmania major promastigotes. Parasitol Res, 80, 235-9. https://doi.org/10.1007/BF00932680
- Buttke TM, McCubrey JA,Owen TC (1993). Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods, 157, 233-40. https://doi.org/10.1016/0022-1759(93)90092-L
- Chang AY, Wang M (2013). In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma. Anticancer Drugs, 24, 251-9. https://doi.org/10.1097/CAD.0b013e32835ba289
- Chao D, Bahl P, Houlbrook S, et al (1999). Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay. Br J Cancer, 81, 1280-4. https://doi.org/10.1038/sj.bjc.6694366
- Domingues PM, Zylberberg R, da Matta de Castro T, Baldotto CS,de Lima Araujo LH (2013). Survival data in elderly patients with locally advanced non-small cell lung cancer. Med Oncol, 30, 449. https://doi.org/10.1007/s12032-012-0449-8
- Fujita Y, Hiramatsu M, Kawai M, et al (2009). Histoculture drug response assay predicts the postoperative prognosis of patients with esophageal cancer. Oncol Rep, 21, 499-505.
- Han M, Liu Q, Yu J, Zheng S (2010). Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer. Clin Chem Lab Med, 48, 863-7. https://doi.org/10.1515/cclm.2010.169
- Higashiyama M, Kodama K, Yokouchi H, et al (2001). Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response. Oncol Rep, 8, 279-83.
- Higashiyama M, Oda K, Okami J, et al (2010). Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. Lung Cancer, 68, 472-7. https://doi.org/10.1016/j.lungcan.2009.07.005
- Higashiyama M, Okami J, Maeda J, et al (2012). Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST). J Thorac Dis, 4, 40-7.
- Inal A, Kaplan MA, Kucukoner, et al (2012). Cisplatin-based therapy for the treatment of elderly patients with nonsmall-cell lung cancer: a retrospective analysis of a single institution. Asian Pacific J Cancer Prev, 13, 1837-40. https://doi.org/10.7314/APJCP.2012.13.5.1837
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kawamura M, Gika M, Abiko T, et al (2007). Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol, 59, 507-13. https://doi.org/10.1007/s00280-006-0292-8
- Khabar KS, al-Zoghaibi F, Dzimiri M, et al (1996). MTS interferon assay: a simplified cellular dehydrogenase assay for interferon activity using a water-soluble tetrazolium salt. J Interferon Cytokine Res, 16, 31-3. https://doi.org/10.1089/jir.1996.16.31
- Lee KH, Lee KY, Jeon YJ, et al (2012). Gefitinib in selected patients with pre-treated non-small-cell lung cancer: results from a phase IV, multicenter, non-randomized study (SELINE). Tuberc Respir Dis (Seoul), 73, 303-11. https://doi.org/10.4046/trd.2012.73.6.303
- Li XD, Han JC, Zhang YJ, Li HB, Wu XY (2013). Common variations of DNA repair genes are associated with response to platinum-based chemotherapy in NSCLCs. Asian Pacific J Cancer Prev, 14, 145-8. https://doi.org/10.7314/APJCP.2013.14.1.145
- Malich G, Markovic B,Winder C (1997). The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology, 124, 179-92. https://doi.org/10.1016/S0300-483X(97)00151-0
- Mercer SJ, Somers SS, Knight LA, et al (2003). Heterogeneity of chemosensitivity of esophageal and gastric carcinoma. Anticancer Drugs, 14, 397-403. https://doi.org/10.1097/00001813-200307000-00002
- Miller AB, Hoogstraten B, Staquet M, Winkler A (1981). Reporting results of cancer treatment. Cancer, 47, 207-14. https://doi.org/10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
- Mohammed Ael S, Eguchi H, Wada S, et al (2012). TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells. Exp Lung Res, 38, 463-74. https://doi.org/10.3109/01902148.2012.731625
- Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
- Noguchi K, Iwahashi M, Tani M, et al (2005). Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay. Anticancer Res, 25, 931-7.
- O'Toole SA, Sheppard BL, McGuinness E, Gleeson NC, Bonnar J (2001). Serous papillary adenocarcinomas of the ovary display heterogeneity in their response to chemotherapy. Int J Gynecol Cancer, 11, 365-71. https://doi.org/10.1046/j.1525-1438.2001.01041.x
- O'Toole SA, Sheppard BL, McGuinness EP, et al (2003). The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours. Cancer Detect Prev, 27, 47-54. https://doi.org/10.1016/S0361-090X(02)00171-X
- Ozols RF, Willson JK, Grotzinger KR, Young RC (1980). Cloning of human ovarian cancer cells in soft agar from malignant and peritoneal washings. Cancer Res, 40, 2743-7.
- Rotter BA, Thompson BK, Clarkin S, Owen TC (1993). Rapid colorimetric bioassay for screening of Fusarium mycotoxins. Nat Toxins, 1, 303-7. https://doi.org/10.1002/nt.2620010509
- Sedlakova I, Laco J, Tosner J, et al (2012). [Proteins of resistence and drug resistence in ovarian carcinoma patients]. Klin Onkol, 25, 457-63.
- Sofian ZM, Abdullah JM, Rahim AA, et al (2012). Cytotoxicity evaluation of vancomycin and its complex with betacyclodextrin on human glial cell line. Pak J Pharm Sci, 25, 831-7.
- van Meerloo J, Kaspers GJ, Cloos J (2011). Cell sensitivity assays: the MTT assay. Methods Mol Biol, 731, 237-45. https://doi.org/10.1007/978-1-61779-080-5_20
- Wu B, Zhu JS, Zhang Y, Shen WM, Zhang Q (2008). Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experience. World J Gastroenterol, 14, 3064-8. https://doi.org/10.3748/wjg.14.3064
- Yoshimasu T, Oura S, Hirai I, et al (2007). Data acquisition for the histoculture drug response assay in lung cancer. J Thorac Cardiovasc Surg, 133, 303-8. https://doi.org/10.1016/j.jtcvs.2006.06.030
- Zubor P, Kajo K, Stanclova A, et al (2008). Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma. Eur J Cancer Prev, 17, 33-8. https://doi.org/10.1097/CEJ.0b013e3280145e4b
Cited by
- A Hybrid Interpolation Weighted Collaborative Filtering Method for Anti-cancer Drug Response Prediction vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.01017